Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
about
Pharmacological treatments for acute hepatitis C infection: a network meta-analysisHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?New treatments for genotype 1 chronic hepatitis C - focus on simeprevirHepatitis C.Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection TreatmentHCV and HIV co-infection: mechanisms and management.A case of erythrodermia from exacerbated psoriasis vulgaris due to treatment of acute hepatitis C.Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysisPeginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.SASLT guidelines: Update in treatment of Hepatitis C virus infection.Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy.How will we manage acute HCV in men having sex with men in the era of all oral therapy?Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Acute HCV in HIV-infected MSM: modes of acquisition, liver fibrosis, and treatment.Advances in the management of HIV/HCV coinfection.Sofosbuvir in the treatment of early HCV infection in HIV-infected men.Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient.Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study.Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failure.Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection.Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases.Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.Ledipasvir and Sofosbuvir in the Treatment of Early Hepatitis C Virus Infection in HIV-Infected Men
P2860
Q24186859-C64A1BD0-B520-4FA1-A5D1-C702D813618EQ26798469-FA842BD5-A4FE-4ED2-A5BD-D4CB0682E849Q26853138-99A914CC-1537-4F1C-A798-C6FFC0E7EDFDQ28084654-0EE8D727-C30E-477A-AFD7-E2D98A083422Q30355190-3E7BB186-33EE-4D82-B89F-697E076149BCQ33576161-4491FEE8-5EA5-491A-9B66-1965C66DB3A7Q35090634-8133CFB1-19B4-4779-9EBD-F68B454C8DF5Q36031470-1AA5A986-DA00-4870-8DAE-F91369BB0B7CQ36123263-E6556F3C-98AE-4B47-9C70-617300ABDCD5Q36330435-1DE73B98-DCD6-4E26-AC99-81A1A8188D2EQ37216507-40A6D972-1C60-4A62-A766-222E8969E343Q38195262-B54B3DEE-AE47-41C0-9A10-9D2045076AE0Q38206215-3610EBF2-9BEA-4DE2-ADD1-9ED399D1C62CQ38261733-B17C572E-1A5D-4730-B49F-1BDADCF5C62BQ38515906-32F909F9-A008-4FBE-B30B-A6DB48A5DD5DQ38543695-D9FEEC4E-CABD-4EEA-BAF8-B6717C068A61Q38693820-A4A4C52D-145C-4900-AB99-31BAA65FB26CQ38759266-341CD725-8CD8-42BB-968F-23734C1AFB3EQ38912794-C3282F79-1724-42BC-A092-F10591C9FE52Q40153096-C97C27E6-F90C-4153-AEE1-CBAE1E3C0084Q40280603-2C61AF3D-0497-480A-9B0B-82AB2AED74DCQ40483611-8B841AF3-E4C7-4E5D-AED7-F23857DAA5F9Q40873991-8D121FF5-6E78-4DDD-BB67-F80B785023F9Q40946051-639A6D1D-DE20-495B-B318-232C887DB4B9Q42205223-54E46197-9A7A-45C3-B3F3-08AF5EA5A878Q49853233-DCF476C9-36D3-4659-88DB-4F8F38542C84Q54243856-A0498DAE-972C-4E4F-ADE3-07E48B6D238BQ57821930-5491AAE0-64CA-4DCA-B697-D1D528F09B93
P2860
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
@en
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
@nl
type
label
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
@en
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
@nl
prefLabel
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
@en
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.
@nl
P2093
P2860
P356
P1476
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men
@en
P2093
Alison J Uriel
Andrea D Branch
Damaris C Carriero
David G Cassagnol
Douglas T Dieterich
Michael P Mullen
New York Acute Hepatitis C Surveillance Network
Rosanne M Hijdra
Wouter O van Seggelen
P2860
P304
P356
10.1093/CID/CIT799
P407
P577
2013-12-13T00:00:00Z